Furthermore, the reduction of liver fibrosis was confirmed in mice receiving PD‐MC by quantitatively analyzing hydroxyproline and fibrotic markers such as, Col1α1, TGF‐β, and TIMP‐1 (Figure 8C,D). This evidence concerns the gene TIMP1 and Hepatic fibrosis.